01 / Contract Profile
75N91019C00022 Federal Contract Award
Agency code 7529
SBIR TOPIC 354: A NOVEL PREDICTIVE TEST FOR RESPONSE TO COMBINATION IMMUNOTHERAPIES FOR PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
02 / Contract Size and Status
What is the recorded size and timing of this contract?
03 / Spending Trend
75N91019C00022 contract spending by fiscal year
Annual net obligations across the complete period available for this agency and PIID, from the first recorded fiscal year through the latest contract action.
Latest fiscal year obligations-$153.0K
FY 2023Net obligationsComplete recorded range
| Fiscal year | Net obligations | Actions | Change |
|---|---|---|---|
| FY 2019 | $1.50M | 1 | — |
| FY 2020 | $0 | 1 | −100.0% |
| FY 2021 | $0 | 2 | — |
| FY 2022 | $0 | 1 | — |
| FY 2023 | -$153.0K | 2 | — |
04 / Federal Buyer
Which organization manages this contract?
| Department | Contracting agency | Contracting office |
|---|---|---|
| HEALTH AND HUMAN SERVICES, DEPARTMENT OF | NATIONAL INSTITUTES OF HEALTH | NIH NCI |
05 / Contractor
Who holds this federal contract?
BIOMARKER STRATEGIES, LLC
UEI MMRCBR1M7WN5 · CAGE 4UPX8
06 / NAICS Industries
Which industries classify this contract?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| 541715 | RESEARCH AND DEVELOPMENT IN THE PHYSICAL, ENGINEERING, AND LIFE SCIENCES (EXCEPT NANOTECHNOLOGY AND BIOTECHNOLOGY) | $1.35M | 7 | 100.0% |
07 / Products and Services
What products or services were purchased?
| Code | Description | Obligations | Actions | Share |
|---|---|---|---|---|
| AN13 | HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT | $1.35M | 7 | 100.0% |
08 / Place of Performance
Where is the work recorded?
DERWOOD, MONTGOMERY, MARYLAND, UNITED STATES
ZIP 208552734
09 / Contract Actions
What modifications and obligations were recorded?
| Signed date | Modification | Obligation | Contracting office | NAICS | PSC |
|---|---|---|---|---|---|
| Aug 15, 2023 | P00006 | -$153.0K | NIH NCIOffice code 75N910 | 541715 | AN13 |
| Mar 23, 2023 | P00005 | $0 | NIH NCIOffice code 75N910 | 541715 | AN13 |
| Jul 28, 2022 | P00004 | $0 | NIH NCIOffice code 75N910 | 541715 | AN13 |
| May 7, 2021 | P00003 | $0 | NIH NCIOffice code 75N910 | 541715 | AN13 |
| Mar 3, 2021 | P00002 | $0 | NIH NCIOffice code 75N910 | 541715 | AN13 |
| Mar 12, 2020 | P00001 | $0 | NIH NCIOffice code 75N910 | 541715 | AN13 |
| Sep 12, 2019 | Base action | $1.50M | NIH NCIOffice code 75N910 | 541715 | AN13 |
10 / Reading the Contract
How should this award record be interpreted?
Read the PIID as a transaction history, not as a single purchase price. Net obligations combine the base action with later increases, reductions, corrections, and deobligations recorded under the same contract.
Verify the buyer
Agency and office identify who manages the procurement relationship.
Follow modifications
Each action can change funding, scope, dates, or administrative terms.
Compare the market
Use NAICS, PSC, and the contractor profile to identify related buyers and competitors.